Pivikto 150mg Tablet

Overview Pivikto 150mg Tablet

Alpelisib 150mg tablets are indicated for treating specific advanced breast cancers: hormone receptor-positive, HER2-negative, and PIK3CA-mutated breast cancer that has metastasized. This medication is administered concurrently with endocrine-based cancer therapies. Consistent daily dosing, ideally with food, at the same time, maximizes therapeutic efficacy. Dosage and frequency are determined individually by your oncologist, based on your specific condition and may be adjusted. Adhere strictly to your physician's instructions; incorrect usage or overdosage can lead to severe adverse effects. While benefits may not be immediately apparent (potentially taking weeks or months), discontinue only under medical supervision. Commonly reported side effects include lethargy, reduced appetite, skin rash, nausea, and diarrhea. Alpelisib can also suppress blood cell production (both red and white cells), increasing vulnerability to infections. Report any signs of infection (fever, chills, weakness, unusual bleeding or bruising, epistaxis) to your doctor promptly. Dizziness is another potential side effect; avoid driving or activities requiring alertness if affected. Prior to commencing treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, and all medications you are taking (including anti-infectives), as drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is mandatory for both partners throughout the treatment period. A patient support program is accessible in India via Tata 1mg; inquire with your doctor or call (1800-102-1618) for further information.

Uses of Pivikto 150mg Tablet

Managing breast cancer

Major Benefits of Pivikto 150mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Pivikto 150mg tablets should be administered with a meal.

Common Side effects of Pivikto 150mg Tablet:

• Diarrhea
• Rash
• Increased glucose level in blood
• Nausea
• Vomiting
• Fatigue
• Increased creatinine level in blood
• Lymphocytopenia
• Increased gamma-glutamyltransferase
• Increased alanine aminotransferase
• Decreased hemoglobin
• Increased lipase in the blood
• Decreased appetite
• Stomatitis (Inflammation of the mouth)
• Weight loss
• Hypoglycemia (low blood glucose level)
• Decreased calcium level in blood
• Prolonged activated partial thromboplastin time (aPTT)
• Hair loss

How to use Pivikto 150mg Tablet:

Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Pivikto 150mg tablets with a meal.

How Pivikto 150mg Tablet works:

Pivikto 150mg tablets combat cancer by inhibiting the signals responsible for cancer cell proliferation, thus hindering tumor growth.

What if you forget to take Pivikto 150mg Tablet :

NA